Negative control of TLR3 signaling by TICAM1 down-regulation.

Shasha Tao, Lingxiang Zhu, Pakkei Lee, Wai-ming Lee, Kenneth Knox, Jie Chen, Yuanpu Peter Di, Yin Chen

School of Public Health, China Medical University, Shenyang, China.

American journal of respiratory cell and molecular biology 2012 May

filter terms:

Toll-IL-1 receptor (TIR) domain-containing adaptor molecule-1 (TICAM1, also called TRIF) is an important adaptor protein in TLR3 and TLR4 signaling pathways that mediate proinflammatory cytokine and IFN responses. Negative regulation of TICAM1 by exogenous viral protease or by endogenous caspase and proteasome have been reported to shut down TICAM1-mediated signaling. In this study, we discovered that down-regulation of TICAM1, but not other components in this signaling pathway, occurred in a natural process of TLR3 activation induced by double-stranded RNA or human rhinovirus (RV) infection in airway epithelial cells and various other cell types. TICAM1 was essential for IFN expression, and the loss of TICAM1 significantly elevated RV production. The low level of TICAM1 protein expression, caused by the prior double-stranded RNA treatment, led to a lack of IFN production upon additional treatment, suggesting receptor desensitization. In follow-up studies, TICAM1 down-regulation was found to be dependent on TLR3 but not RIG1, MDA5, or PKR and appeared to be regulated post-translationally. Neither proteasome nor caspase inhibitors could prevent TICAM1 down-regulation. Instead, a lysosome-mediated process appeared to be involved, suggesting a novel mechanism that is different from previous reports. In conclusion, TICAM1 down-regulation is an essential step in TLR3 activation, and its function is to stop TLR3-mediated IFN production.

Citation

Shasha Tao, Lingxiang Zhu, Pakkei Lee, Wai-ming Lee, Kenneth Knox, Jie Chen, Yuanpu Peter Di, Yin Chen. Negative control of TLR3 signaling by TICAM1 down-regulation. American journal of respiratory cell and molecular biology. 2012 May;46(5):660-7